Epcoritamab Uses, Dosage, Side Effects and more
Epcoritamab is under investigation in clinical trial NCT04628494 (A Phase 3 Trial of Epcoritamab in R/R DLBCL).
| Trade Name | Epcoritamab |
| Generic | Epcoritamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
